JP2015524822A5 - - Google Patents

Download PDF

Info

Publication number
JP2015524822A5
JP2015524822A5 JP2015525605A JP2015525605A JP2015524822A5 JP 2015524822 A5 JP2015524822 A5 JP 2015524822A5 JP 2015525605 A JP2015525605 A JP 2015525605A JP 2015525605 A JP2015525605 A JP 2015525605A JP 2015524822 A5 JP2015524822 A5 JP 2015524822A5
Authority
JP
Japan
Prior art keywords
compound
formula
salt
converting
item
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015525605A
Other languages
English (en)
Japanese (ja)
Other versions
JP6147856B2 (ja
JP2015524822A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/053295 external-priority patent/WO2014022707A1/en
Publication of JP2015524822A publication Critical patent/JP2015524822A/ja
Publication of JP2015524822A5 publication Critical patent/JP2015524822A5/ja
Application granted granted Critical
Publication of JP6147856B2 publication Critical patent/JP6147856B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015525605A 2012-08-03 2013-08-01 インテグラーゼインヒビターを調製するためのプロセスおよび中間体 Expired - Fee Related JP6147856B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261679475P 2012-08-03 2012-08-03
US61/679,475 2012-08-03
PCT/US2013/053295 WO2014022707A1 (en) 2012-08-03 2013-08-01 Process and intermediates for preparing integrase inhibitors

Publications (3)

Publication Number Publication Date
JP2015524822A JP2015524822A (ja) 2015-08-27
JP2015524822A5 true JP2015524822A5 (enExample) 2016-10-06
JP6147856B2 JP6147856B2 (ja) 2017-06-14

Family

ID=48980354

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015525605A Expired - Fee Related JP6147856B2 (ja) 2012-08-03 2013-08-01 インテグラーゼインヒビターを調製するためのプロセスおよび中間体

Country Status (17)

Country Link
US (1) US8877931B2 (enExample)
EP (1) EP2880017B1 (enExample)
JP (1) JP6147856B2 (enExample)
KR (1) KR20150040340A (enExample)
CN (1) CN104520275B (enExample)
AU (1) AU2013296289B2 (enExample)
BR (1) BR112015002275A2 (enExample)
CA (1) CA2878699C (enExample)
EA (1) EA026089B1 (enExample)
ES (1) ES2608860T3 (enExample)
IL (1) IL236618A (enExample)
IN (1) IN2015DN01688A (enExample)
MX (1) MX337094B (enExample)
NZ (1) NZ630199A (enExample)
PT (1) PT2880017T (enExample)
SG (1) SG11201500812QA (enExample)
WO (1) WO2014022707A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ709260A (en) 2012-12-21 2016-07-29 Gilead Sciences Inc Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
NO2865735T3 (enExample) 2013-07-12 2018-07-21
ES2859102T3 (es) 2013-07-12 2021-10-01 Gilead Sciences Inc Compuestos de carbamoilpiridona policíclica y su uso para el tratamiento de infecciones por VIH
TW201613936A (en) 2014-06-20 2016-04-16 Gilead Sciences Inc Crystalline forms of(2R,5S,13aR)-8-hydroxy-7,9-dioxo-n-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide
TWI677489B (zh) 2014-06-20 2019-11-21 美商基利科學股份有限公司 多環型胺甲醯基吡啶酮化合物之合成
NO2717902T3 (enExample) 2014-06-20 2018-06-23
TWI695003B (zh) 2014-12-23 2020-06-01 美商基利科學股份有限公司 多環胺甲醯基吡啶酮化合物及其醫藥用途
SI3466490T1 (sl) 2015-04-02 2020-12-31 Gilead Sciences, Inc. Policiklične spojine karbamoilpiridona in njihova farmacevtska uporaba
CA3160068A1 (en) * 2019-09-24 2021-04-01 Asymchem Laboratories (Tianjin) Co., Ltd. Continuous preparation method for benzylzinc halide and derivative thereof
CN112661698A (zh) * 2021-01-14 2021-04-16 浙江海森药业股份有限公司 一种艾维雷韦的制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9904108D0 (sv) * 1999-11-15 1999-11-15 New Pharma Research Ab Nya föreningar
CN1232508C (zh) 2000-12-14 2005-12-21 宝洁公司 制取喹诺酮和二氮杂萘的环化方法步骤
TW200300349A (en) 2001-11-19 2003-06-01 Sankyo Co A 4-oxoqinoline derivative
US20050104233A1 (en) 2002-05-31 2005-05-19 Shinji Kato Method of substituent introduction through halogen-metal exchange reaction
US6803469B2 (en) 2002-08-05 2004-10-12 The Procter & Gamble Company Process for preparing quinolone antibiotic intermediates
TW200409759A (en) 2002-09-25 2004-06-16 Wyeth Corp Substituted 4-(indazol-3-yl)phenols
DE60329318D1 (de) 2002-11-20 2009-10-29 Japan Tobacco Inc 4-oxochinolinverbindungen und deren verwendung als hiv-integrase-inhibitoren
EP1582523A1 (en) 2004-04-02 2005-10-05 Ludwig-Maximilians-Universität München Method of preparing organomagnesium compounds
EP1582524B1 (en) 2004-04-02 2008-08-13 Ludwig Maximilians Universität Method of preparing organomagnesium compounds
WO2005113509A1 (en) 2004-05-20 2005-12-01 Japan Tobacco Inc. Novel 4-oxoquinoline compound and use thereof as hiv integrase inhibitor
MY134672A (en) 2004-05-20 2007-12-31 Japan Tobacco Inc Stable crystal of 4-oxoquinoline compound
US8633219B2 (en) 2004-05-21 2014-01-21 Japan Tobacco Inc. Combination therapy
WO2007063869A1 (ja) 2005-11-30 2007-06-07 Japan Tobacco Inc. 高純度キノロン化合物の製造方法
US20090233964A1 (en) 2005-12-30 2009-09-17 Gilead Sciences, Inc. Methods for improving the pharmacokinetics of hiv integrase inhibitors
CN101437801B (zh) 2006-03-06 2013-02-06 日本烟草产业株式会社 制备4-氧代喹啉化合物的方法
KR101023635B1 (ko) 2006-03-06 2011-03-22 니뽄 다바코 산교 가부시키가이샤 4-옥소퀴놀린 화합물 제조 방법
TW200811153A (en) 2006-06-23 2008-03-01 Japan Tobacco Inc 6-(heterocyclyl-substituted benzyl)-4-oxoquinoline compound and use thereof as HIV integrase inhibitor
EP2644587A3 (en) 2006-09-12 2013-10-23 Gilead Sciences, Inc. Process and intermediates for preparing integrase inhibitors
AP2490A (en) 2007-06-29 2012-10-04 Gilead Sciences Inc Therapeutic compositions and the use thereof
NZ582086A (en) 2007-06-29 2012-07-27 Gilead Sciences Inc Therapeutic compositions and the use thereof
AR068403A1 (es) 2007-09-11 2009-11-18 Gilead Sciences Inc Proceso e intermediarios para la preparacion de inhibidores de integrasa

Similar Documents

Publication Publication Date Title
JP2015524822A5 (enExample)
JP2019194236A5 (enExample)
JP2010095546A5 (enExample)
JP2019048806A5 (enExample)
JP2015042636A5 (ja) 有機化合物
JP2010174033A5 (enExample)
JP2015181191A5 (enExample)
JP2013532130A5 (enExample)
RU2015148258A (ru) Силоксановое соединение и способ его получения
JP2017514910A5 (enExample)
JP2020500916A5 (enExample)
PH12013500105A1 (en) Process for preparing antiviral compounds
JP2016518317A5 (enExample)
EA201790343A1 (ru) Способ получения сульфамидных производных пиримидина
RU2017102307A (ru) Способ получения синтетического пентапептида
MX2017003238A (es) Metodo para preparar 2'-o-fucosil-lactosa.
WO2016038628A3 (en) A process for preparing olodaterol and intermediates thereof
JP2016513709A5 (enExample)
RU2014129937A (ru) Способы и промежуточные соединения для получения фармацевтических агентов
RU2015111236A (ru) Способ получения производного оксазола
JP2013043794A5 (enExample)
JP2018009003A5 (enExample)
JP2016040296A5 (enExample)
JP2014009330A5 (enExample)
JP2014508179A5 (enExample)